Contents

Current Medicinal Chemistry - Anti-Cancer Agents, Volume 4 - Number 6

Can PPARγ Ligands Be Used in Cancer Therapy?

, 4(6): 465 - 477

M. A.K. Rumi, S. Ishihara, H. Kazumori, Y. Kadowaki and Y. Kinoshita


DOI: 10.2174/1568011043352678




Cytoprotection and Immunomodulation in Cancer Therapy

, 4(6): 479 - 490

Sham Diwanay, Manish Gautam and Bhushan Patwardhan


DOI: 10.2174/1568011043352704




Multiple Targeting by the Antitumor Drug Tamoxifen: A Structure-Activity Study

, 4(6): 491 - 508

Philippe de Medina, Gilles Favre and Marc Poirot


DOI: 10.2174/1568011043352696




Biological Targets of Antitumor Indolocarbazoles Bearing a Sugar Moiety

, 4(6): 509 - 521

Michelle Prudhomme


DOI: 10.2174/1568011043352650




Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment

, 4(6): 523 - 534

J. Narashimamurthy, A. Raghu Ram Rao and G. Narahari Sastry


DOI: 10.2174/1568011043352669




Role of the Non-Neuronal Human Cholinergic System in Lung Cancer and Mesothelioma: Possibility of New Therapeutic Strategies

, 4(6): 535 - 542

Sonya Trombino, Alessandra Bisio, Alessia Catassi, Alfredo Cesario, Carla Falugi and Patrizia Russo


DOI: 10.2174/1568011043352687




An Update on the Systemic Therapy of Malignant Salivary Gland Cancers: Role of Chemotherapy and Molecular Targeted Agents

, 4(6): 543 - 551

M. Agulnik and L. L. Siu


DOI: 10.2174/1568011043352641




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science